JPWO2020264425A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020264425A5
JPWO2020264425A5 JP2021577919A JP2021577919A JPWO2020264425A5 JP WO2020264425 A5 JPWO2020264425 A5 JP WO2020264425A5 JP 2021577919 A JP2021577919 A JP 2021577919A JP 2021577919 A JP2021577919 A JP 2021577919A JP WO2020264425 A5 JPWO2020264425 A5 JP WO2020264425A5
Authority
JP
Japan
Prior art keywords
ophthalmic
haptics
ophthalmic article
item
iol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538347A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039990 external-priority patent/WO2020264425A1/fr
Publication of JP2022538347A publication Critical patent/JP2022538347A/ja
Publication of JPWO2020264425A5 publication Critical patent/JPWO2020264425A5/ja
Pending legal-status Critical Current

Links

JP2021577919A 2019-06-27 2020-06-26 眼用デバイス送達方法およびシステム Pending JP2022538347A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962867233P 2019-06-27 2019-06-27
US62/867,233 2019-06-27
US202063012994P 2020-04-21 2020-04-21
US63/012,994 2020-04-21
PCT/US2020/039990 WO2020264425A1 (fr) 2019-06-27 2020-06-26 Procédés et systèmes de distribution de dispositifs oculaires

Publications (2)

Publication Number Publication Date
JP2022538347A JP2022538347A (ja) 2022-09-01
JPWO2020264425A5 true JPWO2020264425A5 (fr) 2023-07-04

Family

ID=74044213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577919A Pending JP2022538347A (ja) 2019-06-27 2020-06-26 眼用デバイス送達方法およびシステム

Country Status (11)

Country Link
US (2) US11185441B2 (fr)
EP (1) EP3990042A4 (fr)
JP (1) JP2022538347A (fr)
KR (1) KR20220036946A (fr)
CN (2) CN114340690B (fr)
AU (1) AU2020302924A1 (fr)
BR (1) BR112021026265A2 (fr)
CA (1) CA3144406A1 (fr)
GB (1) GB2601922B (fr)
IL (1) IL289374A (fr)
MX (1) MX2021015760A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112689486A (zh) * 2018-07-23 2021-04-20 科罗拉多大学董事会法人团体 用于药物递送的眼科装置
US11399977B2 (en) * 2020-06-04 2022-08-02 SpyGlass Pharma, Inc. Ophthalmic implant system for drug delivery
US20220104936A1 (en) 2020-10-05 2022-04-07 SpyGlass Pharma, Inc. IOL with Drug Delivery Devices and Uninterrupted PCO Barrier Edge
WO2023009654A2 (fr) * 2021-07-28 2023-02-02 SpyGlass Pharma, Inc. Systèmes d'administration de médicament intraoculaire stabilisé et méthodes d'utilisation
EP4376768A1 (fr) 2021-07-30 2024-06-05 Spyglass Pharma, Inc. Systèmes pour fixer des dispositifs à des ensembles de lentilles intraoculaires et procédés associés
CN114381083B (zh) * 2021-12-17 2023-03-24 浙江理工大学上虞工业技术研究院有限公司 一种角膜接触镜用抗菌抗氧化水凝胶及其制备方法
DE102022112803B4 (de) 2022-05-20 2023-12-14 Carl Zeiss Meditec Ag Intraokularlinse mit einem Medikamentenspeicher, angeordnet an einem Haptikarm in einer Radialaussparung
US20240024092A1 (en) * 2022-07-22 2024-01-25 SpyGlass Pharma, Inc. Intraocular drug delivery systems and methods of use
US20240139099A1 (en) * 2022-10-27 2024-05-02 JelliSee Ophthalmics Inc. Drug delivering stretch ring
US20240148488A1 (en) * 2022-11-04 2024-05-09 JelliSee Ophthalmics Inc. Dissolvable stretch ring for intraocular lens

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681102A (en) 1985-09-11 1987-07-21 Bartell Michael T Apparatus and method for insertion of an intra-ocular lens
US4834750A (en) 1987-09-17 1989-05-30 Ioptex Research, Inc. Deformable-elastic intraocular lens
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5290892A (en) 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5554187A (en) 1995-08-18 1996-09-10 Rizzo, Iii; Joseph Medication dispensing intra-ocular lens system
US20020164374A1 (en) 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof
US6679605B2 (en) 2000-05-22 2004-01-20 Medennium, Inc. Crystalline polymeric compositions for ophthalmic devices
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP3167872B1 (fr) 2000-07-05 2020-10-14 Allergan, Inc. Procédés de traitement des états inflammatoires de l' oeil
US6699493B2 (en) 2000-11-29 2004-03-02 Oculex Pharmaceuticals, Inc. Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US6713081B2 (en) 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
GB2399753B (en) 2002-01-18 2006-04-19 Michael E Snyder Method of making a sustained release ophthalmological device
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
JP4791349B2 (ja) 2003-02-28 2011-10-12 バイオインターラクションズ リミテッド 医療機器のためのポリマーネットワークシステム及び使用方法
CN101137338A (zh) * 2003-12-03 2008-03-05 眼睛光学技术公司 混合型可调节性人工晶状体
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8512738B2 (en) 2004-04-30 2013-08-20 Allergan, Inc. Biodegradable intravitreal tyrosine kinase implants
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
EP1611877A1 (fr) 2004-06-28 2006-01-04 Universidade de Coimbra Méthodes pour la préparation d'articles ophthalmiques thérapeutiques à la libération prolongée en utilisant des fluides compressés pour l'imprégnation des medicaments
EP2216026B1 (fr) 2004-07-12 2016-04-20 Allergan, Inc. Compositions ophthalmologiques et leur utilisation pour le traitement des maladies oculaires.
US7931909B2 (en) 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
CA2637602C (fr) 2006-01-17 2014-09-16 Forsight Labs, Llc Dispositif de traitement d'administration de medicament
US20070178138A1 (en) 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
WO2007112946A1 (fr) * 2006-03-30 2007-10-11 Universite De Geneve Cristallin artificiel intégrant un système de libération de médicament
US20070260203A1 (en) 2006-05-04 2007-11-08 Allergan, Inc. Vasoactive agent intraocular implant
US8216603B2 (en) 2006-05-04 2012-07-10 Herbert Edward Kaufman Method, device, and system for delivery of therapeutic agents to the eye
US8039010B2 (en) 2006-11-03 2011-10-18 Allergan, Inc. Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8846073B2 (en) 2006-12-19 2014-09-30 Allergan, Inc. Low temperature processes for making cyclic lipid implants for intraocular use
CA2680831A1 (fr) * 2007-03-14 2008-09-18 University Of Washington Dispositif et procede pour l'administration intraoculaire d'un medicament
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
US8138290B2 (en) 2008-01-25 2012-03-20 Bausch & Lomb Incorporated High water content ophthalmic devices
US8702794B2 (en) 2008-04-28 2014-04-22 Abbott Medical Optics Inc. Back loaded IOL insertion cartridge
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
AU2009246520B2 (en) 2008-05-12 2012-04-19 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US8821870B2 (en) 2008-07-18 2014-09-02 Allergan, Inc. Method for treating atrophic age related macular degeneration
US8343214B2 (en) 2008-10-20 2013-01-01 Cateract Innovations LLC Apparatus for the treatment of cataract
WO2010059214A2 (fr) 2008-11-20 2010-05-27 Insight Innovations, Llc Système d'implant intraoculaire biodégradable et biocompatible
US20120232649A1 (en) * 2008-11-20 2012-09-13 Insight Innovations, Llc Intraocular Lens Cell Migration Inhibition System
WO2010068281A2 (fr) * 2008-12-11 2010-06-17 Massachusetts Institute Of Technology Dispositif d’administration de médicament par lentille de contact
CN105726201B (zh) * 2009-05-18 2020-08-25 多斯医学公司 给药眼植入物
CA2764063C (fr) 2009-06-03 2019-05-14 Forsight Labs, Llc Distribution de medicament de segment anterieur
ES2603057T3 (es) 2009-10-30 2017-02-23 Aton Pharma, Inc. Dispositivos de administración ocular de fármacos
EP2566468A4 (fr) 2010-05-03 2014-06-18 Massachusetts Inst Technology Revêtement de délivrance de médicaments et dispositifs
US20130142858A1 (en) 2010-05-17 2013-06-06 Aerie Pharmaceuticals, Inc. Drug delivery devices for delivery of ocular therapeutic agents
EP2591026B1 (fr) 2010-07-05 2016-05-04 Dave, Jagrat Natavar Dispositif ophtalmique réfractif/diffractif et compositions utiles pour sa fabrication
US20130209538A1 (en) 2010-08-12 2013-08-15 Singapore Health Services Pte Ltd Biodegradable ocular implant
US8715713B2 (en) 2011-04-29 2014-05-06 Allergan, Inc. Solvent cast film sustained release latanoprost implant
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2013040426A2 (fr) 2011-09-14 2013-03-21 Forsight Labs, Llc Appareil et procédés pour insert oculaire
US20130302420A1 (en) 2012-05-14 2013-11-14 Barry L. Bowyer Ocular biodegradable drug implant and method of its use
SG11201500710QA (en) * 2012-08-15 2015-02-27 Univ Nanyang Tech A drug eluting member, a method of attaching the same and a method of fabricating the same, a device for holding the same and a drug eluting device
US10653621B2 (en) 2012-09-27 2020-05-19 Allergan, Inc. Biodegradable drug delivery systems for the sustained release of proteins
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
US20150290170A1 (en) 2012-10-26 2015-10-15 Allergan, Inc. Ketorolac-containing sustained release drug delivery systems
US20150272877A1 (en) 2012-10-26 2015-10-01 Allergan, Inc. Ketorolac-containing sustained release drug delivery systems
CA2901280A1 (fr) 2013-02-15 2014-08-21 Allergan, Inc. Implant a administration de medicament prolongee
CN109568672B (zh) 2013-03-15 2022-06-24 阿勒根公司 含有前列腺胺的眼内植入物
EP2991621B1 (fr) 2013-05-02 2020-12-09 Retina Foundation of the Southwest Implant oculaire à deux couches
EP3351239B1 (fr) 2013-10-31 2020-04-01 Allergan, Inc. Implants intraoculaires contenant un prostamide et leurs procédés d'utilisation
CA2929684C (fr) 2013-11-14 2022-02-22 Jean-Marie Rakic Dispositif oculaire
EP3076948B1 (fr) 2013-12-06 2020-11-18 Allergan, Inc. Implant intra-camérulaire pour le traitement d'une pathologie oculaire
ES2686472T3 (es) 2015-03-10 2018-10-18 Consejo Superior De Investigaciones Científicas Acoplamiento inducido fotoquímicamente de implantes intraoculares
US20180177718A1 (en) 2015-05-29 2018-06-28 Envisia Therapeutics, Inc. Implant for treatment of an ocular condition
WO2017015675A1 (fr) 2015-07-23 2017-01-26 Envisia Therapeutics, Inc. Traitement du glaucome oculaire par l'intermédiaire d'implants intracamérulaires
US11173130B2 (en) 2015-09-24 2021-11-16 Massachusetts Eye And Ear Infirmary Drug delivery system and methods of use
GB201519811D0 (en) 2015-11-10 2015-12-23 Univ Belfast Ocular compositions
CN106729975B (zh) 2015-11-19 2020-04-14 爱博诺德(北京)医疗科技股份有限公司 用于制造人工晶体的材料
CN106901871B (zh) * 2015-12-23 2021-08-24 爱博诺德(北京)医疗科技股份有限公司 具有一个或多个附加部分的人工晶状体
PT109154B (pt) 2016-02-12 2019-11-05 Univ De Coimbra Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
EP3210572A1 (fr) * 2016-02-29 2017-08-30 Elodie Jane Siney Lentille intraoculaire comprenant des microsphères contenant un médicament
JP7003110B2 (ja) 2016-04-20 2022-01-20 ドーズ メディカル コーポレーション 生体吸収性眼球薬物送達デバイス
EP4046609A1 (fr) 2016-09-30 2022-08-24 Mati Therapeutics Inc. Formulation ophtalmique à libération pharmacologique prolongée et ses utilisations
US10603274B2 (en) 2016-09-30 2020-03-31 Mati Therapeutics Inc. Ophthalmic drug sustained release formulation and uses thereof
CN110337296A (zh) 2016-12-27 2019-10-15 犹他大学研究基金会 眼内药物递送装置和相关方法
WO2018175268A1 (fr) 2017-03-19 2018-09-27 Biohealthways, Inc. Système d'administration oculaire de médicament à libération prolongée, implantable, à dégradation biologique
US11696952B2 (en) 2017-08-17 2023-07-11 Lutronic Vision Inc. Nanocapsule-based ocular therapy
CN107595765A (zh) 2017-09-22 2018-01-19 沈阳兴齐眼药股份有限公司 一种眼用缓释药物递送系统及其制备方法
US20190192341A1 (en) 2017-11-09 2019-06-27 Allergan, Inc. Sustained-Release Implants for Lowering Intraocular Pressure with Extended Duration of Effect
CN112351755A (zh) 2018-02-22 2021-02-09 伊万提斯公司 眼部植入物和输送系统
US20200069577A1 (en) 2018-08-30 2020-03-05 Yunxiang Liu Ophthalmic formulations, process for preparing the same and method for administering the same
DE102018129478B4 (de) 2018-11-22 2021-05-27 Carl Zeiss Meditec Ag Ophthalmologisches Implantat mit einem Wirkstoffabgabesystem und Verfahren zum Herstellen eines solchen ophthalmologischen Implantats
WO2020128062A1 (fr) 2018-12-21 2020-06-25 Re-Vana Therapeutics Ltd Compositions oculaires
US20220054408A1 (en) 2018-12-21 2022-02-24 Re-Vana Therapeutics Ltd Coated ocular implants
US20200281767A1 (en) 2019-03-10 2020-09-10 Paloza Llc Ocular agent delivery device, ocular monitoring device and methods thereof
US11039954B2 (en) 2019-03-21 2021-06-22 Microoptx Inc. Implantable ocular drug delivery devices and methods

Similar Documents

Publication Publication Date Title
GB2601922A (en) Ocular device delivery methods and systems
Lee et al. Biodegradable implants for sustained drug release in the eye
JP6511401B2 (ja) 持続型薬物送達インプラント
Ursell et al. Anterior capsule stability in eyes with intraocular lenses made of poly (methyl methacrylate), silicone, and AcrySof
Nishi et al. Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: a preliminary report
US20210220117A1 (en) Intraocular lens comprising drug-containing microspheres
Avitabile et al. Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits
KR20160077121A (ko) 프로스타마이드-함유 안구내 삽입물 및 그것의 사용 방법
CN104661647A (zh) 显示提高的粘膜转移的药物纳米粒子
KR20160100992A (ko) 눈의 병태의 치료를 위한 전방내 이식물
KR20150058510A (ko) 단백질의 지속된 방출을 위한 생물분해성 약물 전달 시스템
JPWO2020264425A5 (fr)
AU2017319728A1 (en) Depot systems comprising glatiramer acetate
JPH04364855A (ja) コートした眼内レンズとそのためのコーティング組成物
Dong et al. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis
JP2020514404A (ja) 眼内薬物送達デバイス及び関連方法
WO2020264425A1 (fr) Procédés et systèmes de distribution de dispositifs oculaires
Schaefer et al. Evaluation of Intracameral Pentablock copolymer Thermosensitive gel for sustained drug delivery to the anterior chamber of the eye
US20220218685A1 (en) Composition for treating eye diseases
JP2023547607A (ja) 活性薬剤を含む眼内インプラント
JPH08175984A (ja) 後発白内障予防剤
JP6543431B2 (ja) 眼内薬物送達デバイスおよび付随する方法
Kiss et al. Ocular implants–a novel approach in ocular drug delivery
Till Collamer intraocular lens implantation with active uveitis
de Juan-Marcos et al. Intravitreal dexamethasone implant migration to the anterior chamber in an aphakic child